Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Phoenix Biotechnology Inc.
DescriptionNeuroprotectant, derivative of PBI-05204
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard Indication Neurology (unspecified)
Indication DetailsTreat neurodegeneration resulting from ischemic stroke
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today